SCP
PGEN icon

SymBiosis Capital Partners’s Precigen PGEN Stock Holding History

SymBiosis Capital Partners’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000,000
Closed -$12.5M – 10
2025
Q4 		$12.5M Buy
+3,000,000
New +$11.6M 11.45% 4

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

SymBiosis Capital Partners's PGEN Position: Q1 2026 in Review

SymBiosis Capital Partners sold out of Precigen (PGEN) in Q1 2026, closing a stake of 3,000,000 shares — an estimated $12.5M sold.

SymBiosis Capital Partners first reported a position in PGEN in Q4 2025 and held it in 1 quarter. The position peaked at $12.5M in Q4 2025. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • SymBiosis Capital Partners reported no remaining Precigen position as of Q1 2026 after selling out during the quarter.
  • SymBiosis Capital Partners sold 3,000,000 Precigen shares in Q1 2026, an estimated $12.5M.
  • SymBiosis Capital Partners first reported a position in Precigen in Q4 2025 and held it in 1 quarter.
  • SymBiosis Capital Partners's Precigen position peaked at $12.5M in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on SymBiosis Capital Partners's 13F filing for Q1 2026, filed 12 May 2026.